Clarithromycin

Products Clarithromycin is commercially available as film-coated tablets, sustained-release tablets, oral suspension, and powder for solution for infusion (Klacid, generics). It has been approved in many countries since 1990. Clarithromycin should not be confused with ciprofloxacin. Structure and properties Clarithromycin (C38H69NO13, Mr = 747.96 g/mol) exists as a white crystalline powder that is practically insoluble … Clarithromycin

Bunazosin

Products Bunazosin is commercially available in the form of sustained-release tablets (Andante). The drug is not registered in many countries. Structure and properties Bunazosin (C19H27N5O3, Mr = 373.4 g/mol) is present in drugs as bunazosin hydrochloride. It is a quinazoline derivative. Effects Bunazosin (ATC C02CA) is antihypertensive. Its effects are due to selective and competitive … Bunazosin

Clascoteron

Products Clascoterone was approved as a cream in the United States in 2020 (Winlevi). Structure and properties Clascoterone (C24H34O5, Mr = 402.5 g/mol) corresponds to the steroid cortexolone-17α-propionate. It exists as a white powder that is practically insoluble in water. Effects Clascoterone has antiandrogenic properties. The effects are due to antagonism at androgen receptors. Androgens … Clascoteron

Buphenin

Products Buphenin was included in Arbid drops in combination with diphenylpyralin until late 2011. Structure and properties Buphenin (C19H25NO2, Mr = 299.41 g/mol), like other sympathomimetics, has structural similarity to catecholamines, for example, epinephrine. Effects Buphenine (ATC C04AA02) is β-sympathomimetic and thus vasodilatory and positively inotropic. Indications No longer commercially available in many countries for … Buphenin

Clavulanic Acid

Products Clavulanic acid is sold exclusively in combinations with antibiotic amoxicillin. In addition to the original Augmentin, numerous generics are also available. Structure and properties Clavulanic acid (C8H9NO5, Mr = 199.16 g/mol) is present in drugs as potassium clavulanate, the potassium salt of clavulanic acid. Potassium clavulanate is a white, crystalline, hygroscopic powder that is … Clavulanic Acid

Cleboprid

Products No drugs containing clebopride are on the market in many countries. Structure and properties Cleboprid (C20H24ClN3O2, Mr = 373.9 g/mol) is present in drugs as clebopride malate, a white crystalline powder that is sparingly soluble in water. Clebopride is a substituted benzamide. Effects Clebopride (ATC A03FA06) has prokinetic and antiemetic properties. Indications For the … Cleboprid

Clemastine

Products Clemastine is commercially available in tablet form and as a solution for injection (Tavegyl). It has been approved in many countries since 1967. Tavegyl gel has been off the market since 2010 because of low demand. It can be replaced, for example, by a dimetindene maleate gel (Fenistil). Structure and properties Clemastine (C21H26ClNO, Mr … Clemastine

Clenbuterol

Products Clenbuterol is not commercially available as a human drug in many countries, but exclusively as a veterinary drug for the treatment of respiratory diseases (e.g., Ventipulmin ad us vet). It is available only on medical prescription. In other countries, clenbuterol is on the market in tablet and drop form (Spiropent). Structure and properties Clenbuterol … Clenbuterol

Budesonide (Inhalation)

Products Budesonide is commercially available as a monopreparation for inhalation as a powder inhaler and suspension (Pulmicort, generics). It is also combined fixed with formoterol (Symbicort Turbuhaler, Vannair Dosage Aerosol). This article refers to monotherapy. Budesonide has been approved in many countries since 1988. Structure and properties Budesonide (C25H34O6, Mr = 430.5 g/mol) is a … Budesonide (Inhalation)